Elsevier expands biopharma base

Science and health publishing giant Elsevier has acquired Windhover Information Inc., a leading biotech and pharma business intelligence provider. linkurl:Windhover;http://www.windhover.com/dotcom/home.asp publishes several journals, such as __In Vivo__, __Start-up__ and __The Regulation Policy Market Access Report__, which cover health care marketplace trends, business strategy, industry deal making, and medical start-ups. Acquiring Windhover adds more than 100 journalists to Elsevier's staff

By | March 11, 2008

Science and health publishing giant Elsevier has acquired Windhover Information Inc., a leading biotech and pharma business intelligence provider. linkurl:Windhover;http://www.windhover.com/dotcom/home.asp publishes several journals, such as __In Vivo__, __Start-up__ and __The Regulation Policy Market Access Report__, which cover health care marketplace trends, business strategy, industry deal making, and medical start-ups. Acquiring Windhover adds more than 100 journalists to Elsevier's staff and is expected to strengthen the company's health care industry coverage. "Adding Windhover's expert analysis of the pharmaceutical and medical device industries to our existing regulatory and general business news services and database expands both the depth and breadth of Elsevier's customer offerings," Elsevier Health Sciences CEO, Brian Nairn, said in a company linkurl:statement.;http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/03-10-2008/0004771023&EDATE= This move comes after linkurl:news;http://www.the-scientist.com/blog/display/54358/ last month that Elsevier was selling Reed Business Information, the company's primary business-to-business publisher, which also produces, among others, __New Scientist__ and __Variety__ magazines.

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. Genetic Analysis Reveals the Evolutionary History of Dogs
  4. March for Science: Dispatches from Washington, DC
AAAS